Shared on17 Sep 25Fair value Decreased 2.43%
Aspen Pharmacare Holdings' consensus price target has decreased to ZAR120.60, reflecting concerns over a sharply higher future P/E and a substantial decline in net profit margin. What's in the News Aspen Pharmacare Holdings Limited announced an annual dividend of ZAR 2.1100 per share.
Shared on23 Apr 25Fair value Decreased 21%
AnalystConsensusTarget has decreased revenue growth from 8.1% to 5.8% and decreased profit margin from 17.7% to 13.9%.
Shared on17 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25Fair value Increased 63%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.